bioAffinity Technologies, Inc. - Common Stock

Share · US09076W1099 · BIAF (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of bioAffinity Technologies, Inc. - Common Stock

Analyst Grade Summary

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

29.04.2026 19:35

Current Prices from bioAffinity Technologies, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
IEX	BIAF	USD	29.04.2026 19:35	2,48 USD	-0,18 USD -6,77 %
NASDAQ	BIAF	USD	29.04.2026 19:20	2,42 USD	-0,24 USD -9,02 %

Share Float & Liquidity

Free Float 96,74 %

Shares Float 4,35 M

Shares Outstanding 4,5 M

Company Profile for bioAffinity Technologies, Inc. - Common Stock Share

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.